on MAAT PHARMA (isin : FR0012634822)
Crossing of Thresholds by Invus Public Equities in MAAT PHARMA
On October 10, 2025, MAAT PHARMA announced that Bermuda-based Invus Public Equities, LP, had fallen below the 5% equity and voting rights thresholds. The announcement comes after the company sold shares on the market on October 7, 2025.
Invus Public Equities now holds 799,583 shares, representing 4.96% of the capital and voting rights of MAAT PHARMA. This transaction implies a reduction in the company's stake in MAAT PHARMA, initially held by Mr. Raymond Debanne.
MAAT PHARMA, listed on Euronext Paris, has a total of 16,135,971 shares, each representing one voting right. This change reflects the readjustment of Invus Public Equities' stakes in the company.
R. E.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all MAAT PHARMA news